Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biogen Inc. (BIIB) had Revenue of $2.80B for the most recently reported fiscal quarter, ending 2026-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-09-30

Income Statement Financials
Revenue	$2.80B
Net Income	$-20.60M
Cost of Goods Sold	$748.40M
Gross Profit	$2.06B
Operating Expenses	$2.68B
Operating Income	$128.40M
Non-Operating Income/Expense	$-137.40M
Pre-Tax Income	$-9.00M
Normalized Pre-Tax Income	$-9.00M
Income after Taxes	$-20.60M
Income from Continuous Operations	$-20.60M
Consolidated Net Income/Loss	$-20.60M
Normalized Income after Taxes	$-20.60M
EBIT	$128.40M
EBITDA	$566.70M
Weighted-Average Shares Outstanding (Basic)	147.80M
Weighted-Average Shares Outstanding (Diluted)	147.80M
Earnings per Share (EPS) (Basic)	$-0.14
Earnings per Share (EPS) (Diluted)	$-0.14
Balance Sheet Financials
Current Assets	$7.58B
Property, Plant, and Equipment	$2.97B
Long-Term Assets	$24.47B
Total Assets	$32.05B
Current Liabilities	$3.90B
Long-Term Debt	$7.29B
Long-Term Liabilities	$9.23B
Total Liabilities	$13.13B
Common Equity	$18.92B
Tangible Shareholders Equity	$-1.45B
Shareholders Equity	$18.92B
Common Shares Outstanding	147.80M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.74B
Cash Flow from Investing Activities	$-4.27B
Cash Flow from Financial Activities	$858.40M
Beginning Cash	$3.01B
End Cash	$1.30B
Increase/Decrease in Cash	$-1.70B
Stock-Based Compensation	$242.90M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.95
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.28
Debt to Equity Ratio	0.41
Gross Margin	73.31%
Operating Margin	4.58%
EBIT Margin	4.58%
EBITDA Margin	--
Pre-Tax Profit Margin	-0.32%
Profit Margin	-0.73%
Free Cash Flow	$1.60B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.34
Receiveable Turnover	1.49
Days Sales in Receivables	60.49
Return on Equity	-0.11%
Return on Tangible Equity	1.42%
Return on Assets	-0.06%
Return on Investments	-0.08%
Book Value Per Share	$128.03
Free Cash Flow per Share	$10.84
Operating Cash Flow per Share	$11.74

Data from Zacks Investment Research, Inc.